MANNKIND CORP (18)
- Business Finance (12)
- Business Operations (2)
- Human Resources (2)
- Uncategorized (2)
- Indenture, dated as of March 4, 2021, by and between MannKind Corporation and U.S. Bank National Association, as Trustee (Filed With SEC on March 5, 2021)
- Supply Agreement, dated as of July 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals S.A.S (Filed With SEC on February 25, 2021)
- Offer Letter, dated August 11, 2003, by and between MannKind and Joseph Kocinsky (Filed With SEC on February 25, 2021)
- MannKind Corporation 2018 Equity Incentive Plan, as amended (Filed With SEC on August 5, 2020)
- Offer Letter, dated May 7, 2020 by and between MannKind and Alejandro Galindo (Filed With SEC on February 25, 2021)
- Description of Common Stock (Filed With SEC on February 25, 2021)
- Amendment No. 4 to Credit and Security Agreement, dated December 7, 2020 by and among the Company, MannKind LLC and MidCap Financial Trust (Filed With SEC on December 7, 2020)
- Purchase Agreement, dated December 7, 2020 by and among the Company, the Acquired Company, the Sellers and the Securityholders Representative (Filed With SEC on December 7, 2020)
- Description of Common Stock (Filed With SEC on February 25, 2020)
- Amendment to Common Stock Purchase Warrant, dated December 22, 2019, by and between MannKind Corporation and CVI Investments, Inc (Filed With SEC on December 23, 2019)
- Form of 5.75% Convertible Senior Subordinated Exchange Notes Due 2024 (included in Exhibit 4.3 as Exhibit A thereto) (Filed With SEC on August 7, 2019)
- Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Convertible Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Promissory Note due December 31, 2020 made by MannKind Corporation in favor of Bruce & Co., Inc., dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Promissory Note due June 30, 2020 made by MannKind Corporation in favor of Bruce & Co., Inc., dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Form of Warrant to Purchase Stock (Filed With SEC on August 7, 2019)
- Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc (Filed With SEC on February 26, 2019)
- Non-Employee Director Compensation Program (Filed With SEC on February 26, 2019)
